IN2014KN00849A - - Google Patents
Info
- Publication number
- IN2014KN00849A IN2014KN00849A IN849KON2014A IN2014KN00849A IN 2014KN00849 A IN2014KN00849 A IN 2014KN00849A IN 849KON2014 A IN849KON2014 A IN 849KON2014A IN 2014KN00849 A IN2014KN00849 A IN 2014KN00849A
- Authority
- IN
- India
- Prior art keywords
- compounds
- prophylaxis
- pain
- disorders
- formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 102000011040 TRPV Cation Channels Human genes 0.000 abstract 1
- 108010062740 TRPV Cation Channels Proteins 0.000 abstract 1
- 125000003917 carbamoyl group Chemical class [H]N([H])C(*)=O 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 125000003226 pyrazolyl group Chemical group 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 150000003672 ureas Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Virology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Anesthesiology (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11008914 | 2011-11-09 | ||
| PCT/EP2012/072140 WO2013068461A1 (fr) | 2011-11-09 | 2012-11-08 | Dérivés de carboxamide et d'urée à base de pyrazolyle substitué portant un fragment phényle remplacé par un groupe contenant o comme ligands des récepteurs vanilloïdes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014KN00849A true IN2014KN00849A (fr) | 2015-10-02 |
Family
ID=47143122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN849KON2014 IN2014KN00849A (fr) | 2011-11-09 | 2012-11-08 |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP2776398B1 (fr) |
| JP (1) | JP6189313B2 (fr) |
| KR (1) | KR101985442B1 (fr) |
| CN (2) | CN103889961A (fr) |
| AR (1) | AR088702A1 (fr) |
| AU (1) | AU2012334065B2 (fr) |
| BR (1) | BR112014011262B1 (fr) |
| CA (1) | CA2854932A1 (fr) |
| ES (1) | ES2823577T3 (fr) |
| HK (1) | HK1201839A1 (fr) |
| IN (1) | IN2014KN00849A (fr) |
| MX (1) | MX2014005610A (fr) |
| TW (1) | TW201326133A (fr) |
| WO (1) | WO2013068461A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016096140A1 (fr) * | 2014-12-19 | 2016-06-23 | Grünenthal GmbH | Procédé pour la préparation de 1-[(hétéroaryl)-méthyl] ou 1- [(aryl)-méthyl] -3- [4-(hydroxyméthyl)-phényl]-urées |
| JPWO2017170884A1 (ja) * | 2016-03-31 | 2019-02-14 | 富士フイルム富山化学株式会社 | 新規なヒドロキサム酸誘導体の製造方法およびその中間体 |
| EP3635022B1 (fr) * | 2017-05-19 | 2025-05-21 | Etna-Tec, Ltd | Procédés de préparation de monomères fluorés fonctionnalisés, monomères fluorés et compositions pour les préparer |
| CN113135856B (zh) * | 2021-04-08 | 2022-10-11 | 天津大学 | 一类3-三氟甲基-5-氰基吡唑化合物及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8998598A (en) * | 1997-09-11 | 1999-03-29 | Nissan Chemical Industries Ltd. | Pyrazole compounds and plant disease control agent |
| US20050197371A1 (en) * | 2003-11-13 | 2005-09-08 | Ambit Biosciences Corporation | Urea derivatives as PDGFR modulators |
| JP2005314407A (ja) * | 2004-03-31 | 2005-11-10 | Nippon Nohyaku Co Ltd | 新規なハロアルキルスルホンアニリド誘導体、除草剤及びその使用方法並びにその中間体 |
| PE20110285A1 (es) * | 2005-10-19 | 2011-06-04 | Gruenenthal Chemie | Derivados de sulfonamidofenil propionamida como ligandos del receptor vaniloide del subtipo 1 |
| JP5399262B2 (ja) * | 2006-12-08 | 2014-01-29 | エグゼリクシス パテント カンパニー エルエルシー | Ｌｘｒおよびｆｘｒのモジュレーター |
| DE102007018151A1 (de) * | 2007-04-16 | 2008-10-23 | Günenthal GmbH | Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln |
| AU2010244684B2 (en) | 2009-05-07 | 2014-07-03 | Grunenthal Gmbh | Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands |
| KR101746016B1 (ko) * | 2009-05-07 | 2017-06-14 | (주) 메디프론디비티 | 바닐로이드 수용체 리간드로서의 치환된 페닐우레아 및 페닐아미드 |
| BR112012021806A2 (pt) * | 2010-03-01 | 2015-09-08 | Myrexis Inc | compostos e seus usos terapêusticos. |
-
2012
- 2012-11-08 TW TW101141480A patent/TW201326133A/zh unknown
- 2012-11-08 IN IN849KON2014 patent/IN2014KN00849A/en unknown
- 2012-11-08 CN CN201280053470.3A patent/CN103889961A/zh active Pending
- 2012-11-08 CA CA2854932A patent/CA2854932A1/fr not_active Abandoned
- 2012-11-08 JP JP2014540453A patent/JP6189313B2/ja active Active
- 2012-11-08 MX MX2014005610A patent/MX2014005610A/es not_active Application Discontinuation
- 2012-11-08 CN CN201710970447.5A patent/CN107739338A/zh active Pending
- 2012-11-08 AU AU2012334065A patent/AU2012334065B2/en active Active
- 2012-11-08 EP EP12781340.0A patent/EP2776398B1/fr active Active
- 2012-11-08 ES ES12781340T patent/ES2823577T3/es active Active
- 2012-11-08 AR ARP120104204A patent/AR088702A1/es unknown
- 2012-11-08 HK HK15102528.0A patent/HK1201839A1/xx unknown
- 2012-11-08 BR BR112014011262-2A patent/BR112014011262B1/pt active IP Right Grant
- 2012-11-08 WO PCT/EP2012/072140 patent/WO2013068461A1/fr active Application Filing
- 2012-11-08 KR KR1020147015424A patent/KR101985442B1/ko active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HK1201839A1 (en) | 2015-09-11 |
| EP2776398B1 (fr) | 2020-09-02 |
| AU2012334065B2 (en) | 2017-06-08 |
| AU2012334065A1 (en) | 2014-05-22 |
| JP6189313B2 (ja) | 2017-08-30 |
| CN103889961A (zh) | 2014-06-25 |
| BR112014011262A2 (pt) | 2017-04-25 |
| BR112014011262B1 (pt) | 2022-02-15 |
| BR112014011262A8 (pt) | 2018-03-06 |
| MX2014005610A (es) | 2014-07-30 |
| AR088702A1 (es) | 2014-06-25 |
| TW201326133A (zh) | 2013-07-01 |
| JP2014532741A (ja) | 2014-12-08 |
| WO2013068461A1 (fr) | 2013-05-16 |
| KR101985442B1 (ko) | 2019-06-03 |
| CA2854932A1 (fr) | 2013-05-16 |
| ES2823577T3 (es) | 2021-05-07 |
| CN107739338A (zh) | 2018-02-27 |
| EP2776398A1 (fr) | 2014-09-17 |
| KR20140091043A (ko) | 2014-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2014000779A (es) | Derivados de carboxamida y urea que contienen pirazol heteroaromatico sustituido como ligandos del receptor de vanilloide. | |
| NZ708593A (en) | Novel pyrazole derivative | |
| MX367623B (es) | 6-amino-nicotinamidas sustituidas como moduladores de kcnq2/3. | |
| MX2014000964A (es) | Derivados aza heterociclicos sustituidos. | |
| PH12015501964A1 (en) | Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c | |
| GEP20156285B (en) | Compounds and compositions as trk inhibitors | |
| MY174788A (en) | Bipyrazole derivatives as jak inhibitors | |
| MX2013008296A (es) | Diarilacetileno hidracido que contiene inhibidores de tirosina quinasa. | |
| MY165113A (en) | Piperidinone carboxamide azaindane cgrp receptor antagonists | |
| MX2013011908A (es) | Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank. | |
| PH12014501514A1 (en) | New azetidine derivatives, pharmaceutical compositions and uses thereof | |
| WO2011107608A8 (fr) | Amides hétérocycliques en tant qu'inhibiteurs de rock | |
| MX342924B (es) | Nuevos compuestos disustituidos de 3,4-diamino-3-ciclobuteno-1,2-d iona para uso en el tratamiento de patologias mediadas por quimiocinas. | |
| NZ630830A (en) | Benzamides | |
| IN2014MN00697A (fr) | ||
| MX342119B (es) | 2-oxi-quinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3. | |
| MX2014000963A (es) | Derivados de carboxamida y urea aromaticos biciclicos sustituidos como ligandos del receptor de vanilloide. | |
| IN2013DN02555A (fr) | ||
| IN2014KN00849A (fr) | ||
| MX2014003584A (es) | Derivados de metanosulfonamida sustituidos como ligandos de receptores vaniloides. | |
| MX342459B (es) | 2-oxo- y 2-tioxo-dihidroquinolin-3-carboxamidas sustituidas, como moduladores de kcnq2/3. | |
| MX2014003455A (es) | Derivados de metanosulfonamida sustituidos con arilo o n-heteroarilo como ligandos de receptor vanilloide. | |
| MX2013006670A (es) | Derivado de 2-carboxamida-4-piperazinil-benzofurano. | |
| IN2014KN00865A (fr) | ||
| MX2015005312A (es) | Derivados de 1h-indazol-3-carboxamida y uso de los mismos como antagonistas de p2y12. |